Confidential treatment has been requested with respect to certain portions of this exhibit pursuant to a request for confidential treatment under Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Omitted portions have been...Confidential Treatment • March 19th, 2009 • MultiCell Technologies, Inc. • Surgical & medical instruments & apparatus • Delaware
This AGREEMENT (“Agreement”), effective as of March 17, 2009, (“Effective Date”) is between MAXIM BIOTECH, INC., a California corporation (“Maxim”), and MULTICELL TECHNOLOGIES, INC., a Delaware Corporation (“MultiCell”).
